Private Equity
Translink Capital Partners has raised $107.5 million for its fourth fund, according to an SEC filing. No target was listed on the document. The Palo Alto, California-based venture firm "helps entrepreneurs develop customer connections and partnerships in Asia."
1 min read · 18 January 2018
Berkeley, California-based Carmot Therapeutics Inc, a biotech company, has secured $15 million in financing. Horizons Ventures and The Column Group led the round. In addition to the funding, Patrick Zhang of Horizons Ventures has become a board observer while Dr. Adriana Tajonar from The Column Group was added to the board of directors.
1 min read · 18 January 2018
Cambridge, Massachusetts-based Pandion Therapeutics, a biotech company, has closed $58 million in Series A financing. Polaris Partners, Versant Ventures and Roche Venture Fund led the round with participation from SR One and BioInnovation Capital.
1 min read · 18 January 2018
Ring Capital, a Paris-based venture firm, has raised over 140 million euros. The fund's backers include Tikehau Capital, AG2R La Mondiale, BPI France, Bred and Danone. The fund will focus on European growth-stage tech companies. Also, Tikehau has acquired a 25 percent stake in Ring Capital.
3 min read · 18 January 2018
InvestX Master GP1 has launched a growth equity fund that will accept both traditional and digital currency. The minimum fundraising target is $20 million with a hard cap at $100 million. InvestX Global Growth Equity Fund will be available to accredited investors in Canada, the United States and internationally. Vancouver-based InvestX provides accredited investors, family offices, and institutional investors with access to investments in late-stage private companies.
3 min read · 18 January 2018
1 min read · 17 January 2018
Point Richmond, California-based Urban Remedy, a provider of organic, non-GMO and fresh food products, has secured $17 million in Series B funding. The lead investor was 301 INC. In addition to the funding, John Foraker will join Urban Remedy's board of directors.
3 min read · 17 January 2018
Maverick Ventures has raised over $130 million for its debut fund, according to an SEC filing. The early-stage venture firm invests in the healthcare and tech sectors.
1 min read · 17 January 2018
Utah-based Kickstart Seed Fund has closed its fourth fund at $74 million. K4 will focus on making seed and early-stage investments in startups and entrepreneurs based in the Mountain West.
2 min read · 17 January 2018
2 min read · 17 January 2018
